2025 SPS Seattle | Hodgkin Lymphoma Front Line Efficacy and Toxicity Considerations

2025 SPS Seattle | Hodgkin Lymphoma Front Line Efficacy and Toxicity Considerations

Overview

NA

Target Audience

Pharmacists

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Grace Baek, PharmD, BCOP

Date of Release

October 5th, 2025